Our TEAM
We work hard to deliver the best in healthcare innovation and multi-omic insights.
MEET THE PERTHERA
The Leadership Team
The Leadership team at Perthera is dedicated to serving our clients and their patients with the best in clinical decision support. We work hard to deliver the best in healthcare innovation and multi-omic insights.
The Leadership team at Perthera is dedicated to serving our clients and their patients with the best in clinical decision support. We work hard to deliver the best in healthcare innovation and multi-omic insights.
albert Kelley
President & CEO
Over 30 Years Of International Healthcare Technology Leadership From Start-Ups To IPO.
Over 30 Years Of International Healthcare Technology Leadership From Start-Ups To IPO.
Patricia De Arbeloa, MD, MSc
Medical Director
Experienced Medical Director With A Demonstrated History Of Working In The Hospital & Health Care Industry.
Edik Blais, PhD
VP of Research
Biomedical Engineer With Expertise In Cancer Biology, Biostatistics & Data Science.
Nancy Emrick
VP Of Operations
Leading The Commercialization Efforts To Bring Its Best In Class Cancer Care To Patients.
Isaac Hands
Informatics Consultant
Translational Cancer Informatics Specialist With Over 20 Years of Academic Research, Public Sector, and Industry Experience.
David C. Halverson, MD
VP for Clinical Development
Board Certified Medical Oncologist with 25 years of practice experience. NCI trained and 6 years as Senior Clinical Staff NCI BMT.
Chip Petricoin, PhD
Chief Science Officer
George Mason University Professor, School Of Systems Biology Co-Director, Center For Applied Proteomics And Molecular Medicine.
Michael Pishvaian, MD, PhD
Chief Medical Officer
Oncologist And Director Of Clinical Research Programs For Johns Hopkins Kimmel Cancer Center.
Aurelija Urbonaviciute
Director, European Operations
16+ Years Of Experience In Product Development And Tech Leadership Roles. Ex Startup CEO.
Senait Fesseha
VP Of Finance
20+ Years Of Experience In Financial Analytics And Business Operations With Focus On Operational Efficiency And Quality.
MEET THE PERTHERA
Board Members
At Perthera we strive to surround ourselves with a Board of Directors who can help us grow our business and improve our processes. Our board is made up of recognized leaders across many areas of expertise and contribute significant amounts of time, talent, and energy to further the mission of our company.
At Perthera we strive to surround ourselves with a Board of Directors who can help us grow our business and improve our processes. Our board is made up of recognized leaders across many areas of expertise and contribute significant amounts of time, talent, and energy to further the mission of our company.
albert Kelley
Board Member
Over 30 Years Of Start-Up To IPO International Medical Businesses Including Market Research, Clinical Trials, Market Strategy Development And Execution, And Establishing And Managing High Performance Direct Foreign Operations, Joint Ventures, And Specialty Distributors In Europe, Middle East, South America, And Asia/Pacific Region.
Over 30 Years Of Start-Up To IPO International Medical Businesses Including Market Research, Clinical Trials, Market Strategy Development And Execution, And Establishing And Managing High Performance Direct Foreign Operations, Joint Ventures, And Specialty Distributors In Europe, Middle East, South America, And Asia/Pacific Region.
Andrew Black
Board Member
Andrew Is A Serial Entrepreneur And Investor Working With The Best Minds In Government And Industry, Helping To Build Data-Driven Solutions For The Complex International Challenges Of Our Era. Andrew Is An Accomplished Sales Leader In Federal And Large Multinational Corporations, And His Technology Expertise Is In AI/ML, DevSecOps, And Quantum Information Systems.
Andrew Is A Serial Entrepreneur And Investor Working With The Best Minds In Government And Industry, Helping To Build Data-Driven Solutions For The Complex International Challenges Of Our Era. Andrew Is An Accomplished Sales Leader In Federal And Large Multinational Corporations, And His Technology Expertise Is In AI/ML, DevSecOps, And Quantum Information Systems.
Einaras Von Gravrock
Board Member
Serial Entrepreneur And Technology Investor. Einaras Founded CUJO AI To Secure Everything That Connects To The Internet, Becoming By Far The Biggest IoT Security Company Protecting More Than 1.5 Billion Devices And 40M Homes. Notable Achievements: Founded, Let CUJO AI To Become The Largest IoT Security Firm In The World. Named A “Technology Pioneer” By The World Economic Forum And Invited To Attend Davos In 2019. Named A “Global Innovator” By The World Economic Forum In 2020.
Serial Entrepreneur And Technology Investor. Einaras Founded CUJO AI To Secure Everything That Connects To The Internet, Becoming By Far The Biggest IoT Security Company Protecting More Than 1.5 Billion Devices And 40M Homes. Notable Achievements: Founded, Let CUJO AI To Become The Largest IoT Security Firm In The World. Named A “Technology Pioneer” By The World Economic Forum And Invited To Attend Davos In 2019. Named A “Global Innovator” By The World Economic Forum In 2020.
Nan Hayworth, MD
Board Member
-
-
Yehuda Neuberger
Board Member
Yehuda Neuberger Is The President Of Brownstone Recovery Group. Neuberger Is An Active Private Equity Investor With Investments In A Range Of Companies In Various Sectors Including Financial Services, Back Office Processing, And Business Software. Neuberger Serves On The Boards Of Directors For Many Companies And Not-For-Profit Institutions, Including Publicly-Held Maiden Holdings. From 2001 To 2008, Neuberger Was Executive Vice President Of American Stock Transfer & Trust Company, And Continues To Serve On Its Board And On The Board Of Its International Parent, Armor Holdco. Prior To That, Neuberger Was An Attorney With The Firm Of Weil, Gotshal & Manges, LLP. Neuberger Is A Graduate Of Johns Hopkins University And Harvard Law School.
Yehuda Neuberger Is The President Of Brownstone Recovery Group. Neuberger Is An Active Private Equity Investor With Investments In A Range Of Companies In Various Sectors Including Financial Services, Back Office Processing, And Business Software. Neuberger Serves On The Boards Of Directors For Many Companies And Not-For-Profit Institutions, Including Publicly-Held Maiden Holdings. From 2001 To 2008, Neuberger Was Executive Vice President Of American Stock Transfer & Trust Company, And Continues To Serve On Its Board And On The Board Of Its International Parent, Armor Holdco. Prior To That, Neuberger Was An Attorney With The Firm Of Weil, Gotshal & Manges, LLP. Neuberger Is A Graduate Of Johns Hopkins University And Harvard Law School.
Donna Tuths
Board Member
-
-
Margot P. Schoenborn
Board Observer
Margot Schoenborn is Vice President, Head of Oncology Strategy & Business Management for Laboratory Corporation of America Holdings (“Labcorp”) (NYSE:LH), and S&P 500 company headquartered in Burlington, North Carolina. Margot is responsible for driving the oncology strategy across drug development and diagnostic segments and manages the precision medicine drug development sales and client services teams. Margot joined Labcorp in July 2021 through its acquisition of OmniSeq, Inc., where she served as Chief Executive Officer and Board Director from May 2019 through July 2021. Margot was part of the Roswell Park Comprehensive Cancer Center team, where she served as Deputy General Counsel, that spun out OmniSeq in 2015, and held roles as OmniSeq’s CAO & General Counsel from 2015 through her appointment as CEO of OmniSeq in 2019 after OmniSeq secured its Series B funding. Margot continued as VP, Head of OmniSeq through December 2022 when OmniSeq was fully integrated into Labcorp. Margot is a seasoned business executive and attorney with experience in corporate development, transactions, capital market activities, corporate finance, and leadership of multi-functional teams over 20+ year career in healthcare, state and federal healthcare law enforcement, and commercial litigation. Margot received her JD, cum laude, from University at Buffalo School of Law, where she served as Editor in Chief of the Human Rights Law Review. Margot received her bachelor degree cum laude from Nazareth College. Margot lives in Buffalo, New York with her husband, Jeff, and their two boys.
Margot Schoenborn is Vice President, Head of Oncology Strategy & Business Management for Laboratory Corporation of America Holdings (“Labcorp”) (NYSE:LH), and S&P 500 company headquartered in Burlington, North Carolina. Margot is responsible for driving the oncology strategy across drug development and diagnostic segments and manages the precision medicine drug development sales and client services teams. Margot joined Labcorp in July 2021 through its acquisition of OmniSeq, Inc., where she served as Chief Executive Officer and Board Director from May 2019 through July 2021. Margot was part of the Roswell Park Comprehensive Cancer Center team, where she served as Deputy General Counsel, that spun out OmniSeq in 2015, and held roles as OmniSeq’s CAO & General Counsel from 2015 through her appointment as CEO of OmniSeq in 2019 after OmniSeq secured its Series B funding. Margot continued as VP, Head of OmniSeq through December 2022 when OmniSeq was fully integrated into Labcorp. Margot is a seasoned business executive and attorney with experience in corporate development, transactions, capital market activities, corporate finance, and leadership of multi-functional teams over 20+ year career in healthcare, state and federal healthcare law enforcement, and commercial litigation. Margot received her JD, cum laude, from University at Buffalo School of Law, where she served as Editor in Chief of the Human Rights Law Review. Margot received her bachelor degree cum laude from Nazareth College. Margot lives in Buffalo, New York with her husband, Jeff, and their two boys.
MEET THE PERTHERA
Medical, Scientific, And Senior Advisors
Members of Perthera’s Medical, Scientific, and Senior Advisory Board are leaders and experts in their industries. They provide high level intellectual and strategic guidance to the team and support our company with their experience, contacts and wealth of ideas.
Members of Perthera’s Medical, Scientific, and Senior Advisory Board are leaders and experts in their industries. They provide high level intellectual and strategic guidance to the team and support our company with their experience, contacts and wealth of ideas.
John L. Marshall, MD
Scientific Advisor
Jonathan Brody, Ph. D.
Scientific Advisor
